Advertisement
UK markets close in 4 hours 3 minutes
  • FTSE 100

    8,342.74
    +29.07 (+0.35%)
     
  • FTSE 250

    20,421.21
    +8.13 (+0.04%)
     
  • AIM

    778.14
    +1.72 (+0.22%)
     
  • GBP/EUR

    1.1623
    -0.0001 (-0.01%)
     
  • GBP/USD

    1.2495
    -0.0014 (-0.11%)
     
  • Bitcoin GBP

    49,780.07
    -1,467.29 (-2.86%)
     
  • CMC Crypto 200

    1,322.19
    +27.52 (+2.12%)
     
  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     
  • DOW

    38,884.26
    +31.99 (+0.08%)
     
  • CRUDE OIL

    77.60
    -0.78 (-1.00%)
     
  • GOLD FUTURES

    2,322.40
    -1.80 (-0.08%)
     
  • NIKKEI 225

    38,202.37
    -632.73 (-1.63%)
     
  • HANG SENG

    18,313.86
    -165.51 (-0.90%)
     
  • DAX

    18,502.29
    +72.24 (+0.39%)
     
  • CAC 40

    8,150.55
    +74.87 (+0.93%)
     

Why Guardant Health Crushed the Market Today

Guardant Health announced that it has increased its cooperation with that pharmaceutical company, the sprawling Merck & Co. (NYSE: MRK). The deal centers on the former company's GuardantINFORM diagnostics platform, which Merck will use to help develop the products in its precision oncology pipeline. Guardant data scientists will work closely with their Merck colleagues to disseminate the data supplied by the platform, the company said.